Melola Discovery

← Melola Discovery

Jurnal Tanpa peringkat SINTA

HPV DNA Testing in Cervical Cancer Screening: Challenges, Opportunities, and Future Directions

Scientific Of Environmental Health and Diseases · Vol. 5 No. 1 (2025) · hlm. 42–53

DOI
10.22437/e-sehad.v5i2.41351
ISSN
2774-4337
Terbit
2025-06-30
Penerbit
LPPM Universitas Jambi
Bahasa
en

Abstrak

Background: HPV DNA testing is increasingly recommended as a primary method for cervical cancer screening due to its high sensitivity and strong ability to detect high-risk HPV infections associated with cervical cancer. However, implementation remains challenging in many settings, particularly in low- and middle-income countries, due to health system, economic, and sociocultural barriers. This narrative review highlights key challenges, opportunities, and future directions for HPV DNA testing in cervical cancer screening programs. Methods: A narrative review was conducted by searching PubMed, Scopus, and Google Scholar, complemented by relevant guidelines and reports from international organizations such as the World Health Organization (WHO). Keywords included HPV DNA testing, cervical cancer screening, primary HPV screening, self-sampling, and implementation barriers. The evidence was synthesized thematically to summarize major barriers, innovative strategies, and future perspectives. Results: HPV DNA testing offers superior sensitivity compared with cytology and VIA, enabling earlier detection of precancerous lesions and allowing longer screening intervals. Major challenges include limited laboratory capacity, high costs, supply chain constraints, insufficient workforce training, weak referral and follow-up systems, and sociocultural factors such as stigma and low screening acceptance. Key opportunities include HPV self-sampling to expand screening coverage, risk-based triage using HPV genotyping to reduce unnecessary referrals, and digital health integration to improve tracking, monitoring, and continuity of care. Conclusion: HPV DNA testing has strong potential to strengthen cervical cancer screening and support elimination efforts, but successful scale-up requires addressing system-level barriers, ensuring sustainable financing, improving follow-up pathways, and expanding equitable access through innovations such as self-sampling and risk-based strategies.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 143 tautan kepenulisan bersama · 9 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Jambi
  • Universitas Pembangunan Nasional Veteran Jakarta
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Erny KusdiyahUniversitas Jambi12
Armaidi DarmawanUniversitas Jambi12
Ima MariaUniversitas Pembangunan Nasional Veteran Jakarta7
Nuriyah NuriyahUniversitas Jambi6
Huntari HarahapUniversitas Jambi3
Andika SulistiawanUniversitas Jambi3
Ahmad SyauqyUniversitas Jambi2
Putri Sari WulandariUniversitas Jambi2
Maria Estela KarolinaUniversitas Jambi2
Tia Wida EkaputriUniversitas Jambi2
Rina Nofri EnisUniversitas Jambi2
Nyimas Natasha Ayu ShafiraUniversitas Jambi2
NuriyahAfiliasi tidak diketahui2
AuroraAfiliasi tidak diketahui2
Miftahurrahma MiftahurrahmaUniversitas Jambi1
Fadli FadliAfiliasi tidak diketahui1
Ave Olivia RahmanUniversitas Jambi1
Nuri Putri HarissaUniversitas Jambi1
Herlambang HerlambangUniversitas Jambi1
Putri AkbiditaUniversitas Jambi1
Michelle GracellaUniversitas Jambi1
Imat RahmatillahAfiliasi tidak diketahui1
Maulina AnalitaAfiliasi tidak diketahui1
Maulina AnalitaAfiliasi tidak diketahui1
Imat RahmatilahAfiliasi tidak diketahui1
Esa Indah AyudiaUniversitas Jambi1
Hanina HaninaUniversitas Jambi1
Emildan PasaiAfiliasi tidak diketahui1
Ringa Raudhatul Akbar NuliAfiliasi tidak diketahui1
HaninaAfiliasi tidak diketahui1
Zahra Frizki AstyUniversitas Jambi1
Mirna Marhami IskandarUniversitas Jambi1
Nur Afifa RakfiAfiliasi tidak diketahui1
Risa Nada ZahraAfiliasi tidak diketahui1
Patrick William GadingUniversitas Jambi1
Tengku Arief Buana PerkasaUniversitas Jambi1
Mara Imam Taufiq SiregarUniversitas Jambi1
Hafizah HafizahUniversitas Jambi1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://online-journal.unja.ac.id/index.php/e-sehad/oai, pertama di-harvest 6 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">HPV DNA Testing in Cervical Cancer Screening: Challenges, Opportunities, and Future Directions</dc:title>
	<dc:creator xml:lang="en">Aurora, Wahyu Indah Dewi</dc:creator>
	<dc:creator xml:lang="en">Dwiza, Mutiara</dc:creator>
	<dc:subject xml:lang="en">HPV DNA testing</dc:subject>
	<dc:subject xml:lang="en">cervical cancer screening</dc:subject>
	<dc:subject xml:lang="en">primary HPV screening; self-sampling</dc:subject>
	<dc:subject xml:lang="en">implementation challenges</dc:subject>
	<dc:subject xml:lang="en">public health programs</dc:subject>
	<dc:subject xml:lang="en">cervical cancer prevention</dc:subject>
	<dc:description xml:lang="en">Background: HPV DNA testing is increasingly recommended as a primary method for cervical cancer screening due to its high sensitivity and strong ability to detect high-risk HPV infections associated with cervical cancer. However, implementation remains challenging in many settings, particularly in low- and middle-income countries, due to health system, economic, and sociocultural barriers. This narrative review highlights key challenges, opportunities, and future directions for HPV DNA testing in cervical cancer screening programs.
Methods: A narrative review was conducted by searching PubMed, Scopus, and Google Scholar, complemented by relevant guidelines and reports from international organizations such as the World Health Organization (WHO). Keywords included HPV DNA testing, cervical cancer screening, primary HPV screening, self-sampling, and implementation barriers. The evidence was synthesized thematically to summarize major barriers, innovative strategies, and future perspectives.
Results: HPV DNA testing offers superior sensitivity compared with cytology and VIA, enabling earlier detection of precancerous lesions and allowing longer screening intervals. Major challenges include limited laboratory capacity, high costs, supply chain constraints, insufficient workforce training, weak referral and follow-up systems, and sociocultural factors such as stigma and low screening acceptance. Key opportunities include HPV self-sampling to expand screening coverage, risk-based triage using HPV genotyping to reduce unnecessary referrals, and digital health integration to improve tracking, monitoring, and continuity of care.
Conclusion: HPV DNA testing has strong potential to strengthen cervical cancer screening and support elimination efforts, but successful scale-up requires addressing system-level barriers, ensuring sustainable financing, improving follow-up pathways, and expanding equitable access through innovations such as self-sampling and risk-based strategies.</dc:description>
	<dc:publisher xml:lang="en">LPPM Universitas Jambi</dc:publisher>
	<dc:date>2025-06-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://online-journal.unja.ac.id/e-sehad/article/view/41351</dc:identifier>
	<dc:identifier>10.22437/e-sehad.v5i2.41351</dc:identifier>
	<dc:source xml:lang="en">Scientific Of Environmental Health and Diseases; Vol. 5 No. 1 (2025): Scientific of Environmental Health And Diseases; 42-53</dc:source>
	<dc:source>2774-4337</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://online-journal.unja.ac.id/e-sehad/article/view/41351/23453</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 Scientific Of Environmental Health and Diseases (e-SEHAD)</dc:rights>
</oai_dc:dc>